IL1B and endothelial dysfunction: Given the known mechanistic connections of BET inhibitors to interleukin-1β (IL-1β) (30) for modulating inflammatory phenotypes, an IL-1β–induced model of endothelial dysfunction was used to recapitulate PH features in vitro (31).